Literature DB >> 29170500

White matter disease: Targeted aspartoacylase gene therapy reverts Canavan disease.

Shimona Starling.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29170500     DOI: 10.1038/nrneurol.2017.170

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.

Authors:  Georg von Jonquieres; Ziggy H T Spencer; Benjamin D Rowlands; Claudia B Klugmann; Andre Bongers; Anne E Harasta; Kristina E Parley; Jennie Cederholm; Orla Teahan; Russell Pickford; Fabien Delerue; Lars M Ittner; Dominik Fröhlich; Catriona A McLean; Anthony S Don; Miriam Schneider; Gary D Housley; Caroline D Rae; Matthias Klugmann
Journal:  Acta Neuropathol       Date:  2017-11-07       Impact factor: 17.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.